Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns. Presenting below are its Q1 FY26 earnings results.
Q1 FY26 Earnings Results
-
Revenue from Operations: ₹176 crores, up 8% YoY (Q1 FY25: ₹170.2 crores).
-
EBITDA: ₹52.4 crores, up 19% YoY, with EBITDA margin improving to 27% (Q1 FY25: 26%).
-
Profit After Tax (PAT): ₹20.5 crores, up 11% YoY (Q1 FY25: ₹17.9 crores), PAT margin of 11%.
-
Earnings Per Share (EPS): ₹6.03, up 7% YoY.
-
Retail Touchpoints: Increased significantly from 362 to 2,414 in one year, with retail now contributing ~6% of total revenue.
-
Patient Served & Tests Conducted: 5 million patients served, 16 million tests performed in Q1.
-
Major Contract Win: Secured a large 5-year PPP pathology contract in Rajasthan involving 42 mother labs, 135 satellite labs, and 1,300+ collection centers; expected annual revenue of ₹300–350 crores on maturity, with ₹200–250 crores CapEx planned and phased implementation over 6–9 months.
-
Expansion: Added 3 labs, 2 CT scanners, and 3 MRI machines during the quarter.
Management Commentary & Strategic Highlights
-
MD Yash Mutha expressed optimism about the transformative Rajasthan PPP contract, which will significantly expand Krsnaa’s footprint and revenue base from FY27.
-
The company continues to focus on scaling retail diagnostics, improving operational efficiencies, and digital initiatives to sustain growth and margins.
-
Working capital has improved with overdue receivables from states like Himachal Pradesh and Karnataka beginning to clear, aiding cash flow stability.
-
Retail business projected to reach EBITDA breakeven by FY26 end, with revenue contribution expected to increase to 5–8% by FY26 and 18–20% within two years.
Q4 FY25 Earnings Results
-
Revenue from Operations: ₹175 crores.
-
EBITDA: ₹44 crores; margin ~28%.
-
PAT: ₹21 crores.
-
EPS: ₹6.53.
To view the company’s previous earnings and latest concall transcripts, click here to visit the Alphastreet India news channel.